Literature DB >> 2866783

A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.

J W Rigby, A K Scott, G M Hawksworth, J C Petrie.   

Abstract

Six elderly patients with established hypertension and six young healthy subjects were studied after 8 days of treatment with atenolol 50 mg day-1, metoprolol 50 mg day-1, oxprenolol 80 mg day-1 and propranolol 80 mg day-1. The area under the blood concentration-time curve was increased in the elderly group for each drug, but the difference was statistically significant only for atenolol. The lower serum albumin concentrations in the elderly group did not result in a decrease in the percentage of propranolol or oxprenolol bound to serum proteins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866783      PMCID: PMC1400877          DOI: 10.1111/j.1365-2125.1985.tb05072.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  21 in total

1.  Simplified method for the determination of oxprenolol and other beta-receptor-blocking agents in biological fluids by gas-liquid chromatography.

Authors:  P H Degen; W Riess
Journal:  J Chromatogr       Date:  1976-06-09

2.  Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

Authors:  K M Piafsky; O Borgå
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

3.  A sensitive gas chromatographic method for the determination of propranolol in human plasma.

Authors:  E Di Salle; K M Baker; S R Bareggi; W D Watkins; C A Chidsey; A Frigerio; P L Morselli
Journal:  J Chromatogr       Date:  1973-09-26

4.  Effect of cigarette smoking on phenacetin metabolism.

Authors:  E J Pantuck; K C Hsiao; A Maggio; K Nakamura; R Kuntzman; A H Conney
Journal:  Clin Pharmacol Ther       Date:  1974-01       Impact factor: 6.875

5.  A computerized cummulative integral method for the precise measurement of the glomerular filtration rate. 1.

Authors:  J D Harries; R R Mildenberger; A S Malowany; K N Drummond
Journal:  Proc Soc Exp Biol Med       Date:  1972-09

6.  The effect of ageing on the hepatic clearance of propranolol.

Authors:  C M Castleden; C F George
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

7.  Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man.

Authors:  C G Regårdh; K O Borg; R Johansson; G Johnsson; L Palmer
Journal:  J Pharmacokinet Biopharm       Date:  1974-08

8.  Protein binding of atenolol and propranolol to human serum albumin and in human plasma [proceedings].

Authors:  H E Barber; G M Hawksworth; N R Kitteringham; J Petersen; J C Petrie; J M Swann
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

9.  The effect of age on plasma levels of propranolol and practolol in man.

Authors:  C M Castleden; C M Kaye; R L Parsons
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

10.  The gas chromatographic determination of atenolol in biological samples.

Authors:  B Scales; P B Copsey
Journal:  J Pharm Pharmacol       Date:  1975-06       Impact factor: 3.765

View more
  20 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 2.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

Review 3.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 4.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 5.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

6.  Stereoselective binding of propranolol in the elderly.

Authors:  P Colangelo; M Chandler; R Blouin; P McNamara
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

Review 7.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

Review 8.  Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.

Authors:  R W Piepho; K J Fendler
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

9.  The effect of age on diurnal variation in the pharmacokinetics of propranolol in hypertensive subjects.

Authors:  T Shiga; A Fujimura; T Tateishi; K Ohashi; A Ebihara
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Comparison of pharmacokinetic profiles of single and multiple doses of a slow release Oros oxprenolol delivery system in young normotensive and elderly hypertensive subjects.

Authors:  I D Bradbrook; M Babiker; P Crome; H C Gillies; P J Morrison; H J Rogers; P Shotton
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.